Vice President, Clinical Development – Rheumatology, Rare and Maternal Fetal Immunology (MFI)

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com

Job Function:
Discovery & Pre-Clinical/Clinical Development

Job Sub Function:
Clinical Development & Research – MD

Job Category:
People Leader

All Job Posting Locations:
Spring House, Pennsylvania, United States of America

Job Description:

Johnson & Johnson is currently seeking a Vice President, Clinical Development – Rheumatology, Rare and Maternal Fetal Immunology (MFI) to join our Late Stage Clinical Development team located in Spring House, PA. 

At Johnson & Johnson, we believe health is everything.

Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal.

Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more at https://www.jnj.com/. 

This position works with the Head of Clinical Development (CD) and Head, Early Development (ED), to refine the vision, mission and strategic objectives of drug development.

As a member of the Development Leadership Team, contributes to Immunology Development functional organization by managing the talent strategy, operational excellence and efficiency, and drive key innovation initiatives. 

The VP Clinical Development, Rheumatology, Rare & MFI  is accountable for the design, implementation and reporting of all Late-stage Phase II and III relevant therapy area clinical trials development in Janssen’s Immunology portfolio.  Candidates should have the ability to adapt their therapy area knowledge and expertise to lead and advise on immuno-inflammatory indications based on the needs of the portfolio.  The successful candidate will have exceptional clinical development, functional-leadership and communications skills as well as a high degree of curiosity, innovation, entrepreneurship and a keen sense of patient unmet need.

Responsibilities will include: contribution to the Immunology Therapeutic Area (TA) strategy and governance bodies, accountability for program reviews in the broader Janssen R&D structure, and overall strategy and execution for all therapy area relevant late-stage clinical development programs through product licensing.  This role also has substantial responsible for defining Late Stage Development appro...